UCB Biopharmaceutical Manufacturing Facility at Rowen

planned

UCB Inc., a global biopharmaceutical company based in Brussels, Belgium, plans to invest $2 billion to build a 460,000-square-foot medical science manufacturing facility in Gwinnett County, Georgia. The facility will be the anchor tenant of the 2,000-acre Rowen life sciences campus, modeled after North Carolina's Research Triangle. The project is expected to create more than 330 jobs and serve as a hub for UCB's U.S. manufacturing operations. The design and construction of the facility are expected to take six to seven years. Gwinnett County is providing $174 million in incentives, including property tax breaks, fee waivers, and utility improvements, while the Georgia Department of Economic Development will provide a $3.3 million grant for site preparation costs. UCB plans to leverage artificial intelligence, robotics, and automation in the facility, with expected salaries exceeding $72,000.